BusinessHealthScienceTop Stories

Global HIV Diagnostic Market Report 2019 Estimating CAGR 10.4% Growth by 2024, A report by Siemens AG, F. Hoffmann-La Roche AG, Abbott, Danaher, Thermo Fisher Scientific, Merck KGaA and others

HIV Diagnostic market report is an in-depth study of the Healthcare industry while elucidating market definition, classifications, applications, engagements, and global industry trends.

The HIV Diagnostic report is a direct window to the HIV Diagnostic market as it consists of the activities of the key players and brands when it comes to recent developments, products launches, research, joint ventures, mergers, and acquisitions. Several market players are looking out on for better business strategies to garner a global footprint. A SWOT analysis is useful to determine the market drivers and restraints. The HIV Diagnostic market report holds a deep research study of market drivers and restraints as well as the CAGR levels for the forecasted years of 2019-2024.

Download Sample PDF Report

Major market drivers and restraints Increasing healthcare expenditure on HIV, Increasing prevalence of HIV/AIDS, Increasing number of blood transfusions and blood donations, Government Initiatives, Growing technological advancement, Strict regulatory scenario

Major Market Competitors: Global HIV Diagnosis Market

  • Siemens AG
  • Hoffmann-La Roche AG
  • Abbott
  • Danaher
  • Thermo Fisher Scientific
  • Merck KGaA
  • Bio-Rad Laboratories
  • Hologic
  • bioMerieux SA
  • Alere Inc
  • AbbVie Inc.
  • Johnson & Johnson Services Inc.
  • Bristol-Myers Squibb Company
  • Zyomyx
  • PointCare
  • Sysmex Partec
  • Apogee Flow Systems Ltd
  • Sysmex Corporation, and ViiV Healthcare group of companies
  • Gilead
  • Quest Diagnostics Incorporated
  • Agilent Technologies among others.

Avail Awesome Discount

Market Analysis The Global HIV Diagnosis Market accounted to USD 2.25 billion in 2018 growing at a CAGR of 10.4% during the forecast period of 2019 to 2024. The upcoming market report contains data for historic years 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2024.

Strategic Points Covered in TOC:
·Chapter 1: Introduction, market driving force product scope, market risk, market overview, and market opportunities of the global HIV Diagnosis market
·Chapter 2: Evaluating the leading manufacturers of the global HIV Diagnosis market which consists of its revenue, sales, and price of the products
·Chapter 3: Displaying the competitive nature among key manufacturers, with market share, revenue, and sales
·Chapter 4: Presenting global HIV Diagnosis market by regions, market share and with revenue and sales for the projected period
·Chapter 5, 6, 7, 8 and 9: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions.


Market Segmentation: Global HIV Diagnosis Market

  • By product type the HIV diagnosis market is segmented into consumables, assay, kits, and reagents, other consumables, instruments, software and services.
  • By test type the HIV diagnosis market is segmented into antibody tests, CD4 count, viral load, early infant and viral identification.
  • Antibody tests are further segmented into ELISA, rapid, and western blot.
  • By product the HIV diagnosis market is segmented into assay, kit, reagent, instrument, software, and services.
  • On the basis of end-users the HIV diagnosis market is segmented into diagnostic laboratories, hospitals, research institutes, and others.

Market Segment by Regions, regional analysis covers:

  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, UK, Russia and Italy)
  • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • South America (Brazil, Argentina, Colombia)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Analysis The global HIV diagnosis market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of HIV diagnosis market for global, Europe, North America, Asia Pacific and South America.

Speak to Author


Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *